An antibiotic stewardship programme and health-related quality of life in patients on haemodialysis: A prospective cohort study
Published
August 12, 2024
Paper ID
PAP-000176
Status
Published
DOI
10.65712/tmj.test000434
Advance Services
Abstract
Background: Practice around an antibiotic stewardship programme varies widely between centres. Methods: The primary outcome was health-related quality of life, assessed blind to allocation. Results: 1783 participants were included (median age 30 years). health-related quality of life occurred in 9% of the intervention group versus 21% of controls. Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
health-related quality of life remains a leading cause of avoidable harm among patients on haemodialysis. The cost of health-related quality of life to health systems is substantial.
health-related quality of life remains a leading cause of avoidable harm among patients on haemodialysis. Guidelines make only a weak recommendation on an antibiotic stewardship programme. The cost of health-related quality of life to health systems is substantial.
The cost of health-related quality of life to health systems is substantial. Guidelines make only a weak recommendation on an antibiotic stewardship programme.
Earlier studies of an antibiotic stewardship programme were small or single-centre. The cost of health-related quality of life to health systems is substantial. Practice around an antibiotic stewardship programme varies widely between centres. Guidelines make only a weak recommendation on an antibiotic stewardship programme.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients on haemodialysis.
Missing data were handled with multiple imputation. Eligible participants were patients on haemodialysis.
Missing data were handled with multiple imputation. We conducted a prospective cohort study across 7 centres between 2016 and 2025. Eligible participants were patients on haemodialysis. Analyses were adjusted for age, sex and baseline severity.
Results
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.73 (95% CI 0.44 to 0.93). 2056 participants were included (median age 38 years).
2287 participants were included (median age 51 years). Effects were consistent across prespecified subgroups. health-related quality of life occurred in 4% of the intervention group versus 18% of controls.
| Group | n | Events |
|---|---|---|
| Female | 769 | 107 |
| Centre B | 357 | 19 |
| Centre B | 810 | 16 |
Values are n (%) unless stated otherwise.

Shown for patients on haemodialysis; error bars are 95% confidence intervals.

Shown for patients on haemodialysis; error bars are 95% confidence intervals.
976 participants were included (median age 39 years). Effects were consistent across prespecified subgroups.
3584 participants were included (median age 40 years). Effects were consistent across prespecified subgroups.
Discussion
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
These findings suggest that an antibiotic stewardship programme is associated with better health-related quality of life in patients on haemodialysis. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. These findings suggest that an antibiotic stewardship programme is associated with better health-related quality of life in patients on haemodialysis.
Conclusions
An antibiotic stewardship programme should be considered for patients on haemodialysis to improve health-related quality of life.
References
1. Mensah V, Lindqvist N, et al. Prone positioning and glycaemic control. Diabetes Care. 2017;357(7):831-1658.
2. Herrera T, Osei O, et al. Vitamin D supplementation and emergency department revisits. BMJ. 2017;177(2):879-1341.
3. Volkov C, Rossi O, et al. Tranexamic acid and surgical site infection. N Engl J Med. 2016;173(2):575-1535.
4. Nakamura Z, Mueller D, et al. Early mobilisation and medication adherence. BMC Med. 2018;192(5):390-1627.
5. Nasser O, Andersen F, et al. Early mobilisation and glycaemic control. Lancet. 2014;256(6):167-1757.
6. Farouk G, Kim J, et al. Pharmacist-led medication review and chronic pain scores. Pediatrics. 2020;49(5):685-1550.
7. Haddad S, Mueller V, et al. High-flow nasal oxygen and length of stay. JAMA. 2020;228(6):326-1090.
Appendices
The statistical analysis plan is in the online supplement.